Acquiring a MIS Market Position
Rumor has it Enovis is acquiring Novastep from Amplitude Surgical SAS, a public company listed on the Paris stock exchange. The gold nuggets for Enovis in the Novastep portfolio are the MIS portfolio and Fusionframe external fixation.
Novastep MIS portfolio?
MIS is a rapidly growing sector of the foot and ankle space and Novastep has a solid position. First launched in 2019, PECA implant systems for MIS bunion cuts and fixation underwent updates in 2021 with the launch of a guided instrumentation and implant platform PecaPlasty for percutaneous bunion correction.
Enovis is a player
With sales of $1.4 billion and growing at a robust 27.3%, annually, Enovis is ranked 6th among the largest orthopedic companies. Watch for its continued push in the foot and ankle space.
Recent Posts
See AllBioAventis has agreed to sell its wound business to LifeNet Health, which includes skin substitutes TheraSkin and TheraGenesis. The transaction includes a total cash consideration of $85 million. Indu
Dr. Ned Amendola MD, FAAOS, FRCS(C) from Duke University was named second vice president of the American Academy of Orthopedic Surgeons (AAOS) and will ascend to president in 2025-2026. Fellowship tra
As speculated in February 2023 FIX, Enovis announced early this week that it has consummated a deal for Novastep with the MIS bunion system being the prize along with access to a robust OUS sales chan
